CRN

Exclusive Networks Looking To Address Cybersecurity Talent Shortage With CyberFarm

Exclusive Networks just onboarded its 100th student to work in cybersecurity via its CyberFarm program on the Cal Poly San ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...
Philstar.com

Electioneering, duplicate payments plague AICS and AKAP — COA

State auditors flagged mismanagement and political influence in AICS and AKAP, yet the bicameral committee still approved ...
The Manila Times

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...
The Manila Times

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...